$142 Million is the total value of Birchview Capital, LP's 60 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 28.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FHTX | Sell | FOGHORN THERAPEUTICS INC | $2,272,000 | -41.4% | 264,843 | -7.0% | 1.60% | -43.2% |
| BHVN | Sell | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | $2,227,000 | +1.9% | 14,730 | -1.8% | 1.57% | -1.4% |
| SLNO | Sell | SOLENO THERAPEUTICS INC | $409,000 | -39.9% | 245,127 | -93.3% | 0.29% | -41.8% |
| CGEM | Sell | CULLINAN MANAGEMENT INC | $322,000 | -44.3% | 25,114 | -44.3% | 0.23% | -46.0% |
| AWH | Sell | ASPIRA WOMEN'S HEALTH INC | $22,000 | -55.1% | 60,070 | -27.7% | 0.02% | -58.3% |
| ZNTL | Exit | ZENTALIS PHARMACEUTICALS INC | $0 | – | -8,000 | -100.0% | -0.16% | – |
| TPTX | Exit | TURNING POINT THERAPEUTICS INC | $0 | – | -8,000 | -100.0% | -0.44% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2022-11-28
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACCELERATE DIAGNOSTICS INC | 36 | Q3 2023 | 34.6% |
| QUIDELORTHO CORP | 36 | Q3 2023 | 8.6% |
| MASIMO CORP | 36 | Q3 2023 | 2.2% |
| PIONEER NATURAL RESOURCES CO (PXD) | 36 | Q3 2023 | 0.7% |
| XENCOR INC | 35 | Q3 2023 | 0.4% |
| NEUROCRINE BIOSCIENCES INC | 33 | Q3 2023 | 7.4% |
| CORCEPT THERAPEUTICS INC | 32 | Q3 2023 | 1.2% |
| BIOGEN INC | 31 | Q2 2022 | 3.1% |
| CONTRAFECT CORP | 30 | Q3 2022 | 1.6% |
| YIELD10 BIOSCIENCE INC | 26 | Q3 2023 | 0.6% |
View Birchview Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SOLENO THERAPEUTICS INC | March 19, 2019 | 742,635 | 2.3% |
| YIELD10 BIOSCIENCE, INC. | December 29, 2017 | 186,079 | 2.2% |
| HANSEN MEDICAL INC | February 16, 2016 | ? | ? |
| METABOLIX, INC. | June 23, 2015 | 749,696 | 2.8% |
View Birchview Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3/A | 2024-02-20 |
| 4/A | 2024-02-20 |
| SC 13G/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-04-07 |
| 4 | 2023-03-27 |
| 3 | 2023-02-13 |
View Birchview Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.